EVERETT — Pharmaceutical giant Pfizer will lay off 119 workers this spring at a manufacturing facility in south Everett, according to a notice filed with the state.
Last month, Pfizer said it planned to “wind down construction” at the Seagen facility at 215 Shuksan Way.
At the time, the company said plant workers would be “impacted,” but did not say if they’d be laid off.
According to the WARN notice posted Wednesday, Pfizer will close the facility and lay off 119 plant workers. Layoffs begin June 3.
“This decision is not a reflection on the performances of our colleagues but is in alignment with our site capacity design to meet the needs of the business,” Pfizer said Wednesday in an email to The Daily Herald. “We will make every effort to place impacted colleagues within open roles at the Bothell site.”
The massive 270,000-square-foot facility was originally being built for Seagen, the Bothell-based drug development firm. In August 2023, Seagen signed a $215 million deal with contractor Skanksa to complete the plant by the end of this year.
The cancer-drug developer firm had planned to employ up to 200 people at the facility and manufacture medicine for clinical trials and the commercial market.
Plans changed, however, when Pfizer acquired Seagen for $43 billion in December. The purchase included the Seagen facility that is still under construction.
Instead of Everett, Pfizer will manufacture most of the products at a plant in North Carolina, the company said.
Janice Podsada: 425-339-3097; jpodsada@heraldnet.com;
Talk to us
> Give us your news tips.
> Send us a letter to the editor.
> More Herald contact information.
